The Pittsburgh-based provider will use SomaLogic's clinical research platform and development projects to see how proteomic data can potentially be used to, for instance, inform doctors and patients as to a person's real-time health status or disease risk.
from Section Page News - Modern Healthcare https://ift.tt/3nuWX5a
No comments:
Post a Comment